Related Experiment Video
Updated: Aug 9, 2025

07:01
A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
Published on: February 7, 2025
507
Predicting Delayed Shock in Multisystem Inflammatory Disease in Children: A Multicenter Analysis From the New York
Deborah A Levine1, Vincent Uy1, William Krief2
1From the Departments of Emergency Medicine and Pediatrics, NewYork-Presbyterian/Weill Cornell Medicine, New York.
Pediatric Emergency Care
|February 22, 2023
Summary
Predicting delayed shock in children with multisystem inflammatory disease (MIS-C) is crucial. Elevated C-reactive protein, low lymphocyte percentage, and low platelet count are key indicators of shock risk in MIS-C patients.
Area of Science:
- Pediatric critical care medicine
- Pediatric infectious diseases
- Pediatric rheumatology
Background:
- Multisystem inflammatory disease in children (MIS-C) can lead to shock, a critical complication.
- Early identification of patients at risk for delayed shock is essential for timely intervention.
- Predicting shock development in MIS-C is challenging due to its complex presentation.
Purpose of the Study:
- To identify independent predictors of delayed shock (≥3 hours from ED arrival) in MIS-C patients.
- To develop a predictive model for identifying MIS-C patients at low risk of delayed shock.
- To improve risk stratification and guide clinical management of MIS-C.
Main Methods:
- Retrospective cross-sectional study across 22 pediatric emergency departments.
- Inclusion of patients meeting WHO criteria for MIS-C from April to June 2020.
- Analysis of clinical and laboratory factors associated with delayed shock development.
Main Results:
- Of 248 MIS-C patients, 35% experienced shock, with 66% of those developing delayed shock.
- Independent predictors for delayed shock included CRP > 20 mg/dL, lymphocyte percent < 11%, and platelet count < 220,000/uL.
- A low-risk prediction model (CRP < 6 mg/dL, lymphocyte percent > 20%, platelet count > 260,000/uL) showed 93% sensitivity for identifying patients not progressing to delayed shock.
Conclusions:
- Serum CRP, lymphocyte percentage, and platelet count effectively differentiate risk for delayed shock in MIS-C.
- These laboratory markers can stratify MIS-C patients by shock progression risk.
- The findings aid in situational awareness and guiding the level of care for MIS-C patients.

